Heron Therapeutics, Inc. (NASDAQ:HRTX) recently ticked higher on weak volume. About 0.8 million contracts were traded on 02-Apr-19 compared to daily average volume of 881.59 million shares. The first sale was made at $24.57 but later the stock became weaker, and closed with a gain of 4.11%. It was last traded at $25.56 apiece.

Heron Therapeutics, Inc. (HRTX): Buy Candidate With 110.88% Upside Potential

Heron Therapeutics, Inc. is maintained at an average buy rating by 11 stock analysts, and there are at least 18.02% of shares outstanding that are currently legally short sold. The shares went down by -9.14% in value last month. Year-to-date it plunged -1.46%. Analysts are turning out to be more optimistic than before, with 11 of analysts who cover Heron Therapeutics, Inc. (NASDAQ:HRTX) advice adding it to buy candidate list. Wall Street experts also assign a $53.9 price target on Heron Therapeutics, Inc., pointing towards a 110.88% rally from current levels. The stock is trading for about -40.42% less than its 52-week high.

Heron Therapeutics, Inc. Reports 36.08% Sales Growth

Heron Therapeutics, Inc. (HRTX) remained unsuccessful in beating the consensus-estimated -$0.46 as it actually earned -$0.63 per share in its last reported financial results. Revenue, on the other hand, scored 36.08% growth from the previous quarter, coming up with $26.93 million.

HRTX Adds 6.99% In A Week

This company shares (HRTX) so far managed to recover 20.28% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 3.65% while widening the period to a month, volatility was 3.84%. The share price has already crossed its 20 days moving average, floating at a distance of 3.73% and sits -2.15% lower versus its 50 days moving average. When looking at the past five sessions, the stock returned 6.99% gains and is down by -16.69% compared with its 200-day moving average of $27.31. Also, Heron Therapeutics, Inc. (HRTX) needs to overturn a -3.18% decrease it experienced over the past twelve months.

The Coca-Cola Company (NYSE:KO) Consensus Call At 2.4

As regular trading ended, The Coca-Cola Company (KO) stock brought in a -$0.15 drop to $46.57. The day started at a price of $46.99 but then traded as high as $47.165 before giving part of the gains back. As for this week, analysts appear content to stick with their neutral outlook with the consensus call at 2.4. The Coca-Cola Company is given 5 buy-equivalent recommendations, 0 sells and 14 holds. The company shares sank -8.4% from their peak of $50.84 and now has a $197.9 billion market value of equity.

The Coca-Cola Company Could Grow 7.37% More

KO’s mean recommendation on Reuter’s scale improved from 2.29 thirty days ago to 2.36 now, which indicates a hold consensus from the analyst community. They see The Coca-Cola Company (KO) price hitting a mean target of $50 a share, meaning the stock still has potential that could lift the price another 7.37% . Also, the recent close suggests the stock is underpriced by 20.25% compared to the most bullish target.

The Coca-Cola Company (KO) Returns -1.65% This Year

The company had seen its current volume reaching at 8.3 million shares in the last trade. That compares with the recent volume average of 17.01 million. At the close of regular trading, its last week’s stock price volatility was 1.11% which for the month reaches 1.02%. The Coca-Cola Company dipped to as low as $46.59 throughout the day and has returned -1.65% in this year. At one point in the past year, the shares traded as low as $41.45 but has recovered 12.35% since then. [T4]